Metrics other than potency reveal systematic variation in responses to cancer drugs - Dataset (ID:20120)
Download: Excel (XLSX), Comma-separated (CSV)
| Small Molecule | Cell Line | log10[max. dose (M)] | R^2 (goodness of fit) | log10[EC50 (M)] | log10[IC50 (M)] | log10[GI50 (M)] | HillSlope | E_inf | E_max | AUC |
|---|---|---|---|---|---|---|---|---|---|---|
| Bortezomib | AU565 | -3.7773 | 0.9948 | -7.6683 | -7.6678 | -7.7217 | 3.7605 | 0.0035 | 0.0035 | 2.9784 |
| Ixabepilone | AU565 | -4.4045 | 0.9793 | -8.3790 | -8.3705 | -8.4523 | 3.0590 | 0.0256 | 0.0256 | 2.9694 |
| Geldanamycin | MCF 10A | -4.0000 | 0.9888 | -8.1900 | -8.1632 | -8.2354 | 2.8000 | 0.0602 | 0.0602 | 2.9586 |
| Geldanamycin | SUM149PT | -4.0000 | 0.9686 | -8.1950 | -8.1819 | -8.2478 | 3.9830 | 0.0572 | 0.0572 | 2.9240 |
| Geldanamycin | SUM159PT | -4.0000 | 0.9944 | -8.1560 | -8.1410 | -8.1970 | 2.6035 | 0.0400 | 0.0400 | 2.8392 |
| Ixabepilone | HCC1954 | -4.4045 | 0.9770 | -8.5815 | -8.5657 | -8.6882 | 1.6170 | 0.0543 | 0.0543 | 2.8292 |
| Ixabepilone | HCC1187 | -4.4045 | 0.9872 | -8.6105 | -8.6026 | -8.7327 | 3.2200 | 0.0327 | 0.0327 | 2.8018 |
| Gemcitabine | HCC38 | -3.8416 | 0.9855 | -8.2706 | -8.2417 | -8.3689 | 3.4500 | 0.1041 | 0.1041 | 2.7812 |
| Topotecan | HCC38 | -3.9626 | 0.9866 | -8.3826 | -8.3335 | -8.6100 | 1.5540 | 0.0790 | 0.0790 | 2.7260 |
| Torkinib | MCF7 | -4.3010 | 0.9482 | -10.1570 | -9.6593 | -10.3750 | 0.4305 | 0.1950 | 0.1974 | 2.6031 |
| Gemcitabine | HCC1806 | -3.8416 | 0.9790 | -8.6516 | -8.5897 | -8.7366 | 2.1030 | 0.1252 | 0.1252 | 2.5814 |
| Ixabepilone | MDA-MB-231 | -4.4045 | 0.9286 | -9.2455 | -9.2112 | -9.2591 | 1.4930 | 0.1324 | 0.1324 | 2.3981 |
| Torkinib | HCC38 | -4.3010 | 0.9596 | -8.9020 | -8.8385 | -9.6108 | 0.5908 | 0.0409 | 0.0428 | 2.3342 |
| Torkinib | HCC70 | -4.3010 | 0.9415 | -9.6690 | -9.5655 | -12.1070 | 0.3058 | 0.0350 | 0.0565 | 2.0727 |